Journal
STEM CELL REVIEWS AND REPORTS
Volume 18, Issue 8, Pages 2566-2592Publisher
SPRINGER
DOI: 10.1007/s12015-021-10280-1
Keywords
Cardiovascular diseases; Treatment; SC; ES method
Funding
- Iran University of Medical Sciences
Ask authors/readers for more resources
Cardiovascular diseases are significant causes of mortality and disabilities worldwide. Stem cell-based therapies show promise in treating these diseases, but face challenges. This article discusses the types of stem cells, common methods, and their applications, advantages, and limitations in cardiovascular disease treatment.
Cardiovascular diseases (CVDs) are globally known to be important causes of mortality and disabilities. Common treatment strategies for CVDs, such as pharmacological therapeutics impose serious challenges due to the failure of treatments for myocardial necrosis. By contrast, stem cells (SCs) based therapies are seen to be promising approaches to CVDs treatment. In such approaches, cardiomyocytes are differentiated from SCs. To fulfill SCs complete potential, the method should be appointed to generate cardiomyocytes with more mature structure and well-functioning operations. For heart repairing applications, a greatly scalable and medical-grade cardiomyocyte generation must be used. Nonetheless, there are some challenges such as immune rejection, arrhythmogenesis, tumorigenesis, and graft cell death potential. Herein, we discuss the types of potential SCs, and commonly used methods including embryoid bodies related techniques, co-culture, mechanical stimulation, and electrical stimulation and their applications, advantages and limitations in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available